Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

This is the first known case of parathyroid cancer in a patient with Birt Hogg Dube Syndrome.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

A man with kidney tumors and lung cysts was diagnosed with Birt–Hogg–Dubé syndrome and treated successfully, with genetic testing confirming the diagnosis.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Sorafenib may cause hair loss in a way similar to alopecia areata.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

The document highlights recent findings and treatments in urology, including prostate cancer diagnostics, urinary incontinence, and new therapies.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

WNT10A helps esophageal cancer cells spread and keep renewing themselves.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

Distinct β-catenin patterns are linked to cell growth, not cell death, in lung cancer.

High lactate dehydrogenase activity is not necessary for the growth of squamous cell carcinoma.

Lower SMAD2/3 activation predicts more severe skin cancer.

Targeting lipid metabolism can help treat advanced, resistant cancers.